Marijke Niens

1.2k total citations
20 papers, 735 citations indexed

About

Marijke Niens is a scholar working on Pathology and Forensic Medicine, Immunology and Oncology. According to data from OpenAlex, Marijke Niens has authored 20 papers receiving a total of 735 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pathology and Forensic Medicine, 9 papers in Immunology and 5 papers in Oncology. Recurrent topics in Marijke Niens's work include Immune Cell Function and Interaction (9 papers), Lymphoma Diagnosis and Treatment (9 papers) and Viral-associated cancers and disorders (4 papers). Marijke Niens is often cited by papers focused on Immune Cell Function and Interaction (9 papers), Lymphoma Diagnosis and Treatment (9 papers) and Viral-associated cancers and disorders (4 papers). Marijke Niens collaborates with scholars based in Netherlands, United Kingdom and United States. Marijke Niens's co-authors include Arjan Diepstra, Anke van den Berg, Gerard J. te Meerman, Ilja M. Nolte, Sibrand Poppema, Lydia Visser, S Poppema, Gerrit van der Steege, Ruth F. Jarrett and Michael Schaapveld and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Blood.

In The Last Decade

Marijke Niens

20 papers receiving 725 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marijke Niens Netherlands 13 348 343 317 101 97 20 735
Jordi Juncà Spain 13 177 0.5× 194 0.6× 192 0.6× 76 0.8× 71 0.7× 83 742
Luis Caminal‐Montero Spain 15 103 0.3× 353 1.0× 70 0.2× 40 0.4× 64 0.7× 68 762
Andrea L. Sestak United States 12 143 0.4× 557 1.6× 141 0.4× 122 1.2× 39 0.4× 17 946
Giovanna Motta Italy 15 206 0.6× 187 0.5× 225 0.7× 17 0.2× 53 0.5× 45 621
K. H. Fu China 15 363 1.0× 191 0.6× 455 1.4× 20 0.2× 126 1.3× 26 906
G. Mazzola Italy 14 127 0.4× 215 0.6× 43 0.1× 54 0.5× 51 0.5× 40 607
Antonios Psarras United Kingdom 14 105 0.3× 406 1.2× 112 0.4× 51 0.5× 80 0.8× 27 790
P. Carlier Italy 17 96 0.3× 176 0.5× 177 0.6× 36 0.4× 65 0.7× 47 763
Sara B. Hendrickson United States 7 74 0.2× 118 0.3× 340 1.1× 29 0.3× 52 0.5× 7 824
Katarzyna Romanowska‐Próchnicka Poland 14 161 0.5× 230 0.7× 81 0.3× 30 0.3× 46 0.5× 37 644

Countries citing papers authored by Marijke Niens

Since Specialization
Citations

This map shows the geographic impact of Marijke Niens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marijke Niens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marijke Niens more than expected).

Fields of papers citing papers by Marijke Niens

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marijke Niens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marijke Niens. The network helps show where Marijke Niens may publish in the future.

Co-authorship network of co-authors of Marijke Niens

This figure shows the co-authorship network connecting the top 25 collaborators of Marijke Niens. A scholar is included among the top collaborators of Marijke Niens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marijke Niens. Marijke Niens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Niens, Marijke, et al.. (2019). Functional iron deficiency markers are absent during pregnancy despite evidence of low iron stores. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 56(4). 450–456. 5 indexed citations
2.
Peeters, Frederique E.C.M., Bas Kietselaer, Noreen van der Linden, et al.. (2019). Biological variation of cardiac markers in patients with aortic valve stenosis. Open Heart. 6(1). e001040–e001040. 12 indexed citations
3.
Serreze, David, Marijke Niens, John Kulik, & Teresa P. DiLorenzo. (2016). Bridging Mice to Men: Using HLA Transgenic Mice to Enhance the Future Prediction and Prevention of Autoimmune Type 1 Diabetes in Humans. Methods in molecular biology. 1438. 137–151. 9 indexed citations
4.
Kimenai, Dorien M., Ronald M.A. Henry, Carla Kallen, et al.. (2016). Direct comparison of clinical decision limits for cardiac troponin T and I. Heart. 102(8). 610–616. 62 indexed citations
5.
Cardinaels, Eline P.M., Otto Bekers, Joop ten Kate, et al.. (2015). Clinical Interpretation of Elevated Concentrations of Cardiac Troponin T, but Not Troponin I, in Nursing Home Residents. Journal of the American Medical Directors Association. 16(10). 884–891. 16 indexed citations
6.
Linden, Noreen van der, Lieke J.J. Klinkenberg, Marika Leenders, et al.. (2015). The effect of exercise training on the course of cardiac troponin T and I levels: three independent training studies. Scientific Reports. 5(1). 18320–18320. 12 indexed citations
7.
Serreze, David, Harold D. Chapman, Marijke Niens, et al.. (2011). Loss of Intra-Islet CD20 Expression May Complicate Efficacy of B-Cell–Directed Type 1 Diabetes Therapies. Diabetes. 60(11). 2914–2921. 61 indexed citations
8.
9.
Niens, Marijke, Lydia Visser, Ilja M. Nolte, et al.. (2008). Serum chemokine levels in Hodgkin lymphoma patients: highly increased levels of CCL17 and CCL22. British Journal of Haematology. 140(5). 527–536. 89 indexed citations
10.
Diepstra, Arjan, S Poppema, Lydia Visser, et al.. (2008). HLA‐G protein expression as a potential immune escape mechanism in classical Hodgkin’s lymphoma. Tissue Antigens. 71(3). 219–226. 59 indexed citations
11.
Niens, Marijke, Ruth F. Jarrett, Bouke G. Hepkema, et al.. (2007). HLA-A*02 is associated with a reduced risk and HLA-A*01 with an increased risk of developing EBV+ Hodgkin lymphoma. Blood. 110(9). 3310–3315. 99 indexed citations
12.
Diepstra, Arjan, Gustaaf W. van Imhoff, Henrike E. Karim‐Kos, et al.. (2007). HLA Class II Expression by Hodgkin Reed-Sternberg Cells Is an Independent Prognostic Factor in Classical Hodgkin's Lymphoma. Journal of Clinical Oncology. 25(21). 3101–3108. 87 indexed citations
13.
Niens, Marijke, Anke van den Berg, Arjan Diepstra, et al.. (2006). The Human Leukocyte Antigen Class I Region Is Associated with EBV-Positive Hodgkin's Lymphoma: HLA-A and HLA Complex Group 9 Are Putative Candidate Genes. Cancer Epidemiology Biomarkers & Prevention. 15(11). 2280–2284. 26 indexed citations
14.
Niens, Marijke, Lydia Visser, Ruth F. Jarrett, et al.. (2006). TARC and MDC Are the Only Chemokines with Highly Increased Levels in Serum of Hodgkin Lymphoma Patients.. Blood. 108(11). 2268–2268. 2 indexed citations
15.
Diepstra, Arjan, et al.. (2005). Genetic susceptibility to Hodgkin's lymphoma associated with the human leukocyte antigen region. European Journal Of Haematology. 75(s66). 34–41. 33 indexed citations
16.
Niens, Marijke, et al.. (2005). A factorial experiment for optimizing the PCR conditions in routine genotyping. Biotechnology and Applied Biochemistry. 42(2). 157–162. 10 indexed citations
17.
Diepstra, Arjan, Marijke Niens, Edo Vellenga, et al.. (2005). Association with HLA class I in Epstein-Barr-virus-positive and with HLA class III in Epstein-Barr-virus-negative Hodgkin's lymphoma. The Lancet. 365(9478). 2216–2224. 110 indexed citations
18.
Jong, Mirjam M. de, Marijke Niens, Ilja M. Nolte, et al.. (2005). The Human Leukocyte Antigen Region and Colorectal Cancer Risk. Diseases of the Colon & Rectum. 48(2). 303–306. 6 indexed citations
19.
Diepstra, Arjan, Sibrand Poppema, Gerard te Meerman, et al.. (2005). Polymorphisms and Lack of or Aberrant Expression of HLA Class I and II May Influence Antigen Presentation in Classical Hodgkin Lymphoma.. Blood. 106(11). 20–20. 2 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jordi Juncà Breakdown of academic impact, for papers by Luis Caminal‐Montero Breakdown of academic impact, for papers by Andrea L. Sestak Breakdown of academic impact, for papers by Giovanna Motta Breakdown of academic impact, for papers by K. H. Fu Breakdown of academic impact, for papers by G. Mazzola Breakdown of academic impact, for papers by Antonios Psarras Breakdown of academic impact, for papers by P. Carlier Breakdown of academic impact, for papers by Sara B. Hendrickson Breakdown of academic impact, for papers by Katarzyna Romanowska‐Próchnicka
Rankless by CCL
2026